Kaitlyn D’Onofrio

DocwireNews

A new study examined whether any pre-diagnostic factors may impact the significantly increased mortality rate for <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/medicaid-expansion-may-reduce-cancer-rates-and-save-black-lives/">black women</a> with endometrial cancer compared to white women.&ldquo;Racial disparity in endometrial cancer survival rates is substantial and has increased during the past decade. Endometrial cancer is the most common gynecologic cancer and is diagnosed in 1 in 37 women in the United States. Black women with endometrial cancer have a 90% higher 5-year mortality risk compared with white women, with a 5-year mortality rate of 39% among black women compared with 20% among white women. This higher mortality rate is associated in part with disparities in cancer stage at diagnosis; only 53% of black women receive an early diagnosis,&rdquo; explained the study authors.To collect more information, the researchers performed semistructured interviews with 15 <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/racial-disparities-cancer-mortality/">black endometrial cancer patients</a> either in person or using a secure conferencing platform. They used iterative rounds of inductive coding, case summaries, and coanalysis with community input to conduct an exploratory and descriptive content analysis. The primary outcomes were beliefs, interpretations, and experiences of black women from symptom onset to diagnosis.A total of 15 patients were included; ages ranged from 31 to 72 years. All patients lived in the U.S., specifically in the Puget Sound region of Washington (n=8), California (n=2), Alabama (n=1), Michigan (n=1), Louisiana (n=1), Georgia (n=1), and New York (n=1). During the study, 12 women were receiving adjuvant therapy, suggesting they were either part of a high-risk group or had advanced disease. At the time symptoms began, 13 patients were insured, and all 15 patients opted to receive cancer treatment. Knowledge gaps and silence were observed regarding menopause, misinterpretation of vaginal bleeding, and responses by first-line healthcare practitioners that did not align with the endometrial cancer risk for black women.The study was published in <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2766042">JAMA Network Open</a>.&ldquo;Black women with endometrial cancer described multiple experiences that were associated with care delay independent of health care access. Given the importance of cancer stage at diagnosis to overall cancer prognosis and the lack of interventions to address higher mortality rates among black women with endometrial cancer, these findings represent an important first step toward the development of evidenced-based interventions,&rdquo; the researchers summarized.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Black Women With Endometrial Cancer Have A Higher Mortality Rate—But Why?

Oncology

A new study examined whether any pre-diagnostic factors may impact the significantly increased mortality rate for black women with endometrial cancer compared to white women. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe